TWI346553B
(en )
2011-08-11
Chemokine receptor antagonists
HUP0600858A2
(en )
2008-10-28
Piperizinyilpiperidine derivatives as chemokine receptor antagonists
EP2099454A4
(en )
2010-11-10
Aminopyrrolidines as chemokine receptor antagonists
ZA200800320B
(en )
2009-02-25
Indol-3-carbonyl-spiro-piperidine derivatives as Via receptor antagonists
IL179737A0
(en )
2007-05-15
Indole derivatives as histamine receptor antagonists
TWI341198B
(en )
2011-05-01
Hydroisoindoline tachykinin receptor antagonists
AP2006003840A0
(en )
2006-12-31
Indole-2-carboxamidine derivatives as NMDA receptor antagonists
IL182355A0
(en )
2007-07-24
Thrombin receptor antagonists
IL190686A0
(en )
2008-11-03
Il-21 receptor antagonists
AP1983A
(en )
2009-03-24
Carboxamide derivatives as muscarinic receptor antagonists
ZA200806065B
(en )
2009-07-29
Oxazoloisoquinoline derivatives as thrombin receptor antagonists
HU0501169D0
(en )
2006-02-28
New phenantridine derivatives as selective bradykinin b1 receptor antagonists
ZA200802339B
(en )
2009-10-28
Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists
ZA200609846B
(en )
2008-07-30
Mercaptoimidazoles as CCR2 receptor antagonists
IL185640A0
(en )
2008-01-06
Use of 2-anilino-3 ,4-dihydro-quinazolines as 5ht5a receptor antagonists
AP2008004537A0
(en )
2008-08-31
Muscarinic receptor antagonists
ZA200605574B
(en )
2007-12-27
Hydroisoindoline tachykinin receptor antagonists
GB0525029D0
(en )
2006-01-18
Receptor Antagonist
ZA200608369B
(en )
2009-04-29
Piperazinylpiperidine derivatives as chemokine receptor antagonists
ZA200806223B
(en )
2009-07-29
Muscarinic receptor antagonists
GB0408064D0
(en )
2004-05-12
5-HT2B receptor antagonists
GB0408063D0
(en )
2004-05-12
5-HT2B receptor antagonists
GB0408062D0
(en )
2004-05-12
5-HT2B receptor antagonists
SI1711465T1
(en )
2008-04-30
Hydroisoindoline tachykinin receptor antagonists